IL17A and rheumatoid arthritis: There is now compelling evidence from cell culture and animal studies that excessive levels of pro-inflammatory cytokines produced by RA monocytes and T-cells best exemplified by IL-2, IL-6, IL-12/IL-23 and IL-17 are potent activators of the JAK/STAT pathway.